Lymphotactin Gene Expression in Mast Cells Following Fcε Receptor I Aggregation: Modulation by TGF-β, IL-4, Dexamethasone, and Cyclosporin A

Journal of Immunology

Volumn 158, Issue 3, 1997, Pages 1353-1360

  Rumsaeng, Vanitcha ^a,c   Vliagoftis, Harissios ^a   Oh, Chad K ^b   Metcalfe, Dean D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; CYCLOSPORIN; DEXAMETHASONE; GAMMA CHEMOKINE; GLUCOCORTICOID; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 4; LYMPHOKINE; LYMPHOTACTIN; MACROPHAGE INFLAMMATORY PROTEIN 1; MESSENGER RNA; PROTEIN SYNTHESIS INHIBITOR; SIALOGLYCOPROTEIN; TRANSFORMING GROWTH FACTOR BETA; XCL1 PROTEIN, HUMAN; XCL1 PROTEIN, MOUSE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CAPPING PHENOMENON; CELL LINE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; MAST CELL; MOUSE; PHYSIOLOGY; TIME;

ANIMALS; CELL LINE; CHEMOKINES, C; CYCLOHEXIMIDE; CYCLOSPORINE; DEXAMETHASONE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; INTERLEUKIN-4; LYMPHOKINES; MACROPHAGE INFLAMMATORY PROTEIN-1; MAST CELLS; MICE; MICE, INBRED BALB C; PROTEIN SYNTHESIS INHIBITORS; RECEPTOR AGGREGATION; RECEPTORS, IGE; RNA, MESSENGER; SIALOGLYCOPROTEINS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031068245     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Schall, T. J., K. Bacon, R. D. Camp, J. W. Kaspari, and D. V. Goeddel. 1993. Human macrophage inflammatory protein alpha (MIP-1α) and MIP-1 β chemokines attract distinct populations of lymphocytes. J. Exp. Med. 177:1821.
2. Schall, T. J. 1941. Biology of the RANTES/SIS cytokine family. Cytokine 3:165.
3. Oppenheim, J. J., C. O. C. Zacgaruae, N. Mukaida, and K. Matsushima. 1991. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu. Rev. Immunol. 9:617.
4. Selvan, R. S., J. H. Butterfield, and M. S. Krangel. 1994. Expression of multiple chemokine genes by a human mast cell leukemia. J. Biol. Chem. 269:13893.
5. Keiner, G. S., J. Kennedy, K. B. Bacon, S. Kleyensteuber, D. A. Largaespada, N. A. Jenkins, N. G. Copeland, J. F. Bazan, K. W. Moore, T. J. Schall, and A. Zlotnik. 1994. Lymphotactin: a cytokine that represents a new class of chemokine. Science 266:1395.
6. Kennedy, J., G. S. Keiner, S. Kleyensteuber, T. J. Schall, M. C. Weiss, H. Yssel, P. V. Schneider, B. G. Cocks, K. B. Bacon, and A. Zlotnik. 1995. Molecular cloning and functional characterization of human lymphotactin. J. Immunol. 155: 203.
7. Yoshida, T., T. Imai, M. Kakizaki, M. Nishimura, and O. Yoshie. 1995. Molecular cloning of a novel C or gamma type chemokine. SCM-1. FEBS Lett. 360: 155.
8. + T lymphocytes. Eur. J. Immunol. 25:1744.
9. Plaut, M., J. H. Pierce, C. J. Watson, H. J. Hanley, R. P. Nordan, and W. E. Paul. 1989. Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores. Nature 339:64.
10. Burd, P. R., H. W. Rogers, J. R. Gordon, C. A. Martin, S. Jayaraman, S. D. Wilson, A. M. Dvorak, S. J. Galli, and M. E. Dorf. 1989. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J. Exp. Med. 170:245.
11. Costa, J. J., P. R. Burd, and D. D. Metcalfe. 1993. Mast cell cytokines. In The Mast Cell in Health and Disease. M. K. Kaliner and D. D. Metcalfe, eds. Marcel Dekker, New York, p. 443.
12. Burd, P. R., W. C. Thompson, E. E. Max, and F. C. Mills, 1995. Activated mast cells produce interleukin 13. J. Exp. Med. 181:1373.
13. Galli, S. J. 1990. New insights into the riddle of the mast cells: microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab. Invest. 62:5.
14. Gordon, J. R., and S. J. Galli. 1990. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 346:274.
15. Ansel, J. C., J. R. Brown, D. G. Payan, and M. A. Brown. 1993. Substance P selectively activates TNF-α gene expression in murine mast cells. J. Immunol. 150:4478.
16. Latour, S., C. Bonnerot, W. H. Fridman, and M. Daeron. 1992. Induction of tumor necrosis factor-α production by mast cells via FcγR: role of the FcγRIII γ subunit. J. Immunol. 149:2155.
17. Leal, B. I., P. Conlon, and J. S. Marshall. 1994. IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. J. Immunol. 152:5468.
18. + T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091.
19. Tsai, M., J. Hunt, J. P. Arm, C. London, M. Gurish, and S. J. Galli. 1996. The C1.MC/C57.1(C57) mouse mast cell line is of BALB/c origin and is tumorigenic in BALB/c mice. FASEB J. 10:A1218.
20. Dastych, J., and D. D. Metcalfe. 1994. Stem cell factor induces mast cell adhesion to fibronectin. J. Immunol. 152:213.
21. Butterfield, J. H., D. Weiler, G. Dewald, and G. J. Gleich. 1988. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk. Res. 12:345.
22. Kishi, K. 1985. A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors. Leuk. Res. 9:381.
23. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
24. Bednarczuk, T. A., R. C. Wiggins, and G. W. Konat. 1991. Generation of high efficiency, single-stranded DNA hybridization probes by PCR. Biotechniques 10: 478.
25. Jansen, R., and F. D. Ledley. 1989. Production of discrete high specific activity DNA probes using the polymerase chain reaction. Gene Anal. Tech. 6:79.
26. Mertz, L. M., and A. Rashtchian. 1994. PCR radioactive labeling system: a rapid method for synthesis of high specific activity DNA probes. FOCUS 16:45.
27. Hopp, T. P., and K. R. Woods. 1981. Prediction of protein antigenic determinants from amino acid sequences. Proc. Natl. Acad. Sci. USA 78:3824.
28. Hopp, T. P., and K. R. Woods. 1983. A computer program for predicting protein antigenic determinants. Mol. Immunol. 20:483.
29. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
30. Mercer, J. F., and S. A. Wake. 1985. An analysis of the rate of metallothionein mRNA poly(A)-shortening using RNA blot hybridization. Nucleic Acids Res. 13:7929.
31. Bernstein, P., S. W. Peltz, and J. Ross. 1989. The poly(A)-poly(A)-binding protein complex is a major determinant of mRNA stability in vitro. Mol. Cell. Biol. 9:659.
32. Theoharides, T. C., V. Dimitriadou, R. Letourneau, J. J. Rozniecki, H. Vliagoftis, and W. Boucher. 1993. Synergistic action of estradiol and myelin basic protein on mast cell secretion and brain myelin changes resembling early stages of demyelination. Neuroscience 57:861.
33. Olsson, T. 1994. Multiple sclerosis: cerebrospinal fluid. Ann. Neurol. 36(Suppl.):S100.
34. Gordon, J. R., and S. J. Galli. 1991. Release of both preformed and newly synthesized tumor necrosis factor α(TNF-α)/cachectin by mouse mast cells stimulated via the FcεRI: a mechanism for the sustained action of mast cell-derived TNF-α during IgE-dependent biological responses. J. Exp. Med. 174:103.
35. + lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man. J. Immunol. 141:4158.
36. Ying, S., S. R. Durham, C. J. Corrigan, Q. Hamid, and A. B. Kay. 1995. Phenotype of cells expressing mRNA for Th2-type (interleukin 4 and interleukin 5) and Th1-type (interleukin 2 and interferon 7) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am. J. Respir. Cell Mol. Biol. 12:477.
37. Robinson, D. S., S. Ying, A. M. Bentley, Q. Meng, J. North, S. R. Durham, A. B. Kay, and Q. Hamid. 1993. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J. Allergy Clin. Immunol. 92:397.
38. + T cells, increased Th2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J. Allergy Clin. Immunol. 92:313.
39. Virchow, J. J., C. Walker, D. Hafner, C. Kortsik, P. Werner, H. Matthys, and C. Kroegel. 1995. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. Am. J. Respir. Crit. Care. Med. 151:960.
40. Leung, D. Y. 1995. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J. Allergy Clin. Immunol. 96:302.
41. Hamid, Q., M. Boguniewicz, and D. Y. Leung. 1994. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J. Clin. Invest. 94:870.
42. Frew, A. J., L. M. Teran, J. Madden, A. Trefilieff, J. St. Pierre, A. Semper, M. P. Carroll, and S. T. Holgate. 1995. Cellular changes 24 hours after endobronchial allergen challenge in asthma. Int. Arch. Allergy Immunol. 107:376.
43. Diaz, P., M. C. Gonzalez, F. R. Galleguillos, P. Ancic, O. Cromwell, D. Shepherd, S. R. Durham, G. J. Gleich, and A. B. Kay. 1989. Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions. Am. Rev. Respir. Dis. 139:1383.
44. Garlisi, C. G., A. Falcone, T. T. Kung, D. Stelts, K.I. Pennline, A. J. Beavis, S. R. Smith, R. W. Egan, and S. P. Umland. 1995. T cells are necessary for Th2 cytokine production and eosinophil accumulation in airways of antigen-challenged allergic mice. Clin. Immunol. Immunopathol. 75:75.
45. Hemming, F. W. 1992. Glycoproteins of mammalian and avian cells. In Post-Translational Modifications of Proteins. J. J. Harding and M. J. C. Crabbe, eds. CRC Press, Boca Raton, FL, p. 217.
46. Gross, V., T. Andus, J. Castell, B. D. Vom, P. C. Heinrich, and W. Gerok. 1989. O- and N-glycosylation lead to different molecular mass forms of human monocyte interleukin-6. FEBS Lett. 247:323.
47. Takakura, Y. R., S. Yamamoto, S. Fukuda, and M. Kurimoto. 1996. O-glycosylated species of natural human tumor-necrosis factor-α. Eur. J. Biochem. 235: 431.
48. Conradt, H. S., M. Nimtz, K. E. Dittmar, W. Lindenmaier, J. Hoppe, and H. Hauser. 1989. Expression of human interleukin-2 in recombinant baby hamster kidney, Ltk-, and Chinese hamster ovary cells: structure of O-linked carbohydrate chains and their location within the polypeptide. J. Biol. Chem. 264: 17368.
49. Kaye, R. E., D. A. Fruman, B. E. Bierer, M. W. Albers, L. D. Zydowsky, S. I. Ho, Y. J. Jin, M. C. Castells, S. L. Schreiber, C. T. Walsh, S. J. Burakoff, K. F. Austen, and H. R. Katz. 1992. Effects of cyclosporin A and FK506 on Fcε receptor type I-initiated increases in cytokine mRNA in mouse bone marrow-derived progenitor mast cells: resistance to FK506 is associated with a deficiency in FK506-binding protein FKBP12. Prm: Natl. Acad. Sci. USA 89:8542.
50. Musso, T., D. I. Espinoza, K. Pulkki, G. L. Gusella, D. L. Longo, and L. Varesio. 1990. Transforming growth factor beta down-regulates interleukin-1 (IL-1)-induced IL-6 production by human monocytes. Blood 76:2466.
51. Heinrich, M. C., D. C. Dooley, and W. W. Keeble. 1995. Transforming growth factor-β1 inhibits expression of the gene products for steel factor and its receptor (c-kit). Blood 85:1769.
52. Schleimer, R. P., and B. S. Bochner. 1994. The effects of glucocorticoids on human eosinophils. J. Allergy Clin. Immunol. 94:1202.
53. Corrigan, C. J., Q. Hamid, J. North, J. Barkans, R. Moqbel, S. Durham, E. V. Gemou, and A. B. Kay. 1995. Peripheral blood CD4 but not CD8 T-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy. Am. J. Respir. Cell Mol. Biol. 12: 567.
54. Charlesworth, E. N., S. A. Kagey, R. P. Schleimer, P. S. Norman, and L. M. Lichtenstein. 1991. Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen. J. Immunol. 146:671.
55. Schleimer, R. P. 1990. Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma. Am. Rev. Respir. Dis. 141:559.
56. Wershil, B. K., G. T. Furuta, J. A. Lavigne, A. R. Choudhury, Z. S. Wang, and S. J. Galli. 1995. Dexamethasone or cyclosporin A suppress mast cell-leukocyte cytokine cascades: multiple mechanisms of inhibition of IgE- and mast cell-dependent cutaneous inflammation in the mouse. J. Immunol. 154:1391.
57. Alexander, A. B., N. C. Barnes, and A. B. Kay. 1992. Trial of cyclosporin in corticosteroid-dependent chronic severe asthma. Lancet 339:324.
58. + T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A. Int. Immunol. 7:449.
59. Fukuda, T., J. Asakawa, S. Motojima, and S. Makino. 1995. Cyclosporin A reduces T lymphocyte activity and improves airway hyperresnonsiveness in corticosteroid-dependent chronic severe asthma. Ann. Allergy Asthma Immunol. 75:65.